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the umbilicus. The remainder of the general physical examina-
tion was unremarkable. Laboratory evaluation, including full 
blood count, electrolytes, creatinine, liver function test, urine 
analysis and culture were unremarkable. However, thyroid func-
tion testing displayed a low TSH level because of previous thy-
roidectomy. The patient emergently underwent magnetic reso-
nance imaging (MRI) of the spine, which showed a solitary 33 
mm mass at the T7-8 level. The lesion appeared slightly hyper-
intense on T2 and iso signal intensity on T1-weighted images, 
enhancing homogeneously with intravenous contrast (Fig. 1). 
Initially, other intradural intramedullary tumors such as astro-
cytoma and ependymoma were considered. Although the pa-
tient’s had a history of thyroid carcinoma that had been treated 
2 years earlier with thyroidectomy, ISCM seemed an unlikely 
diagnosis, because the patient was young and there have not 
been any reported cases of ISCM associated with papillary thy-
roid carcinomas. With these study results, surgical exploration 
and excision of the mass was pursued. The patient underwent 
myelotomy via decompressive total laminectomy on T6, 7, 8 
and tumor mass removal was accomplished. After myelotomy 
at the T7 level, a hematoma was identified. Below the T7 level, 
however, a dark-gray, yellowish mass that could be partially as-
pirated, indistinguishable from the surroundings, was identi-
INTRODUCTION
Intramedullary spinal cord metastasis (ISCM) is a rare occur-
rence, and represents 8.5% of central nervous system metastases. 
ISCMs affect 0.1-0.4% of all carcinoma patients and comprise 
1-3% of all intramedullary spinal cord neoplasms6-8). Generally, 
ISCMs arise from primary lung carcinoma, small cell carcino-
ma being the most common neoplasm, with the remainder 
originating from primary carcinomas of the breast, kidney, mel-
anomas or lymphomas9). We report a novel case of an ISCM le-
sion which originates from a primary carcinoma involving the 
thyroid gland10).
CASE REPORT
A 31-year-old man presented with acute onset of paraplegia 
and hypesthesia below the umbilicus. The patient’s history was 
significant for thyroid carcinoma that had been treated 2 years 
earlier with thyroidectomy. 
On neurological examination, the patient presented with para-
plegia which included a negative anal tone and showed positive 
signs of bilateral Babinski reflex. Sensory examination showed 
absence of pain, touch, vibration and temperature sense below 
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radiotherapy often results in stasis of the deficit without im-
provement. However, in combination with chemotherapy, radi-
ation correlates with an increased length of survival. Cytore-
ductive surgery is another treatment option for lesions early in 
the course of neurological deficits. It has not been found to in-
crease the length of survival as compared to other treatment 
modalities.
Our report describes the case of a thoracic spinal cord lesion 
proven to be a metastasis from thyroid carcinoma10). In younger 
patients, both papillary and follicular carcinomas have a more 
than 97% cure rate if treated appropriately. Both papillary and 
follicular carcinomas are typically treated with complete removal 
of the thyroid lobe that harbors the carcinoma, in addition to 
fied. The lesion was dissected out and 
microscopically removed.
Microscopically, the tumor showed a 
complex papillary pattern with invasion 
of the spinal cord. The papillae were 
lined by a layer of cuboidal to low co-
lumnar cells which had ground-glass 
nuclei, nuclear grooves and pseudoin-
clusions. Immunohistochemically, the 
tumor cells displayed diffuse positive 
staining for thyroglobulin and galec-
tin-3. These findings are consistent with 
metastatic papillary carcinoma from the 
thyroid gland (Fig. 2). The patient pro-
gressively showed remarkable neurolog-
ical recovery and after one week, motor 
power was improved to grade 3. He was 
referred to the general surgery depart-
ment for recurrent thyroid carcinoma 
treatment. 
DISCUSSION
ISCM is uncommon neoplastic le-
sions and account for 3-5% of cases of 
myelopathy in patients affected by car-
cinoma7). In the literature, lung carcino-
ma, especially small cell carcinoma, ac-
counts for a majority of cases followed 
by breast carcinoma, melanoma, lym-
phoma, and renal cell carcinoma6,8,12,15). 
The mode of tumor spread to the spinal 
cord is not clear, but the autopsy find-
ings suggest that intramedullary tumor 
may result from hematogenous spread 
via the arterial circulation. As many as 
2% of patients in the end stage of dis-
seminated cancer are found to have 
ISCM. MRI as diagnostic imaging tech-
nique has improved over time. It has 
become the gold standard for diagnosis and evaluation of rare 
tumors, hence the detection rate of ISCM is expected to in-
crease. Presenting symptoms of ISCM usually consist of weak-
ness, followed in frequency by sensory loss, pain and bowel and 
bladder disturbance. Weakness and pain present early, as com-
pared to sensory loss, with sphincter disturbance having the lat-
est onset12). Prognosis of ISCM is compounded by treatment 
modality and tumor type, with lung and breast metastases cor-
relating with the shortest survival. Treatment of ISCM consists 
of immediate steroid bolus, radiation and chemotherapy with 
subtotal cytoreductive surgery and the treatment of choice is 
considered case by case17). High dose dexamethasone may al-
low for limited and transient neurological improvement, while 
Fig. 1. MRI scan of the thoracic spinal cord : sagittal (A) T1-weighted images, sagittal (B) and axial 
(C) gadolinium MRI of the thoracic spine showing a solitary mass in the intramedullary spinal cord 
at T7-8 level. The lesion showed a homogeneous enhancement following intravenous administra-
tion of gadolinium contrast.
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Fig. 2. Microscopically, the tumor shows papillary pattern with invasion of the spinal cord (A). The pa-
pillae are lined by a layer of cuboidal to low columnar cells, with ground-glass nuclei and longitudinal 
grooves (B). The tumor cells show positive immunostaining for thyroglobulin (C) and galectin-3 (D).
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CONCLUSION
ISCM is rare but after the advent of the MRI they are being 
encountered with increasing frequency. This is the fifth docu-
mented case of an intramedullary spinal cord metastatic lesion 
arising from a primary thyroid carcinoma and inter alia. It is 
second documented case of ISCM induced spinal apoplexy af-
ter 190510). Early diagnosis and microsurgical resection can re-
sult in improvement in neurological deficits and in the quality 
of life of patients with ISCMs.
References  
1. Ain KB : Anaplastic thyroid carcinoma : behavior, biology, and thera-
peutic approaches. Thyroid 8 : 715-726, 1998
2. Asadi M, Rokni-Yazdi H, Salehinia F, Allameh FS : Metastatic renal cell 
carcinoma initially presented with an intramedullary spinal cord lesion : 
a case report. Cases J 2 : 7805, 2009
3. Baudin E, Schlumberger M : New therapeutic approaches for metastatic 
thyroid carcinoma. Lancet Oncol 8 : 148-156, 2007
4. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee 
ME, et al. : Efficacy of pazopanib in progressive, radioiodine-refractory, 
metastatic differentiated thyroid cancers : results of a phase 2 consor-
tium study. Lancet Oncol 11 : 962-972, 2010
5. Cady B, Rossi R : An expanded view of risk-group definition in differ-
entiated thyroid carcinoma. Surgery 104 : 947-953, 1988
6. Costigan DA, Winkelman MD : Intramedullary spinal cord metastasis. 
A clinicopathological study of 13 cases. J Neurosurg 62 : 227-233, 1985
7. Dunne JW, Harper CG, Pamphlett R : Intramedullary spinal cord me-
tastases : a clinical and pathological study of nine cases. Q J Med 61 : 
1003-1020, 1986
8. Gazzeri R, Galarza M, Faiola A, Gazzeri G : Pure intramedullary spinal 
cord metastasis secondary to gastric cancer. Neurosurg Rev 29 : 173-
177, 2006
9. Grasso G, Meli F, Patti R, Giambartino F, Florena AM, Iacopino DG : 
Intramedullary spinal cord tumor presenting as the initial manifestation 
of metastatic colon cancer : case report and review of the literature. Spi-
nal Cord 45 : 793-796, 2007
10. Honma Y, Kawakita K, Nagao S : Intramedullary spinal cord and brain 
metastases from thyroid carcinoma detected 11 years after initial diag-
nosis--case report. Neurol Med Chir (Tokyo) 36 : 593-597, 1996
11. Jacobs WB, Perrin RG : Evaluation and treatment of spinal metastases : 
an overview. Neurosurg Focus 11 : e10, 2001
12. Kim TG, Yoon DH, Kim YS : Intramedullary spinal cord metastasis. J 
Korean Neurosurg Soc 31 : 501-504, 2002
13. Klimo P Jr, Schmidt MH : Surgical management of spinal metastases. 
Oncologist 9 : 188-196, 2004
14. Scarano MI, De Rosa M, Panariello L, Carlomagno N, Riegler G, Rossi 
GB, et al. : Familial adenomatous polyposis coli : five novel mutations in 
exon 15 of the adenomatous polyposis coli (APC) gene in Italian pa-
tients. Mutations in brief no. 225. Online. Hum Mutat 13 : 256-257, 
1999
15. Schiff D, O’Neill BP : Intramedullary spinal cord metastases : clinical 
features and treatment outcome. Neurology 47 : 906-912, 1996
16. Varela Rois P, González García J, Regueira Portas M, Martínez Cueto P, 
Azevedo González E : [Spinal hematomas : the spinal apoplexy]. Neu-
rologia 25 : 96-103, 2010
17. Winkelman MD, Adelstein DJ, Karlins NL：Intramedullary spinal cord 
metastasis. Diagnostic and therapeutic considerations. Arch Neurol 44 : 
526-531, 1987
the removal of most or all of the other side. Postoperatively, 
most, but not all, patients with thyroid carcinoma need radio-
active iodine treatments after their surgery. Patients with med-
ullary carcinoma usually do not need iodine therapy because 
medullary carcinoma almost never absorbs the radioactive io-
dine. Some small papillary carcinoma treated with a total thy-
roidectomy may not need iodine therapy as well. These carci-
nomas (medullary and some small papillary carcinoma) are 
often cured with simple (complete) surgical therapy alone3). 
Bleeding from thyroid carcinoma is uncommon. Anaplastic thy-
roid carcinoma (ATC) comprises only 1-3% of all thyroid neo-
plasm1,4). Bleeding from ATC is a rare, but potentially life-threat-
ening complication requiring sophisticated intervention facilities 
which are not usually available at odd hours in emergency1). 
When present, distant metastasis occurs primarily in the lungs 
and to a lesser extent in the bones. The occurrence of metastatic 
lesions with hemorrhage arising from a primary thyroid carci-
noma is extremely rare5). A few cases of lower gastrointestinal 
metastatic hemorrhage were reported, which were also associ-
ated with familial adenomatous polyposis14).
Spinal cord apoplexy is a hemorrhage occurring directly into 
the spinal cord. Spinal cord apoplexy may be due to trauma-
tism, to changes in the coats of the blood-vessels, or to excessive 
blood-pressure. The clot may be as large as an almond, seldom 
larger, with the appearance dependent upon its age. When its 
occurrence is recent it will be red or dark in color, and they tend 
to change to brown or yellow with age. The clot may later be-
come encapsuled by a fibrous deposit. There may be gliomatous 
tumors or acute myelitis involvement12). As this case, spinal cord 
apoplexy was induced by metastatic thyroid tumor bleeding. 
Spontaneous hemorrhage was presumably responsible for the 
acute progress of the myelopathy in our patient. Honma et al.10) 
reported a case of intramedullary metastasis of presumed poor-
ly differentiated thyroid carcinoma associated with a hemor-
rhage caudal to the tumor, identical to the configuration dem-
onstrated in our patient. It is almost impossible to make a 
positive diagnosis because the symptoms of hematomyelia are 
similar. Prompt diagnosis and urgent surgical treatment are 
needed when the patient has neurological symptoms. If the 
hemorrhage is small in quantity, absorption may speedily take 
place with complete recovery16). Prognosis depends upon the 
extent and location of the clot. 
The prognosis of a patient who has an intramedullary cord le-
sion is grave, and treatment is mostly undertaken to relieve pain 
and to preserve or stabilize neurologic function. Medical and 
surgical interventions and radio-therapy have controversially 
been used as a therapeutic modality. 
Advent of new surgical strategies including radiotherapy, would 
make an improvement for ISCM treatment modalities. Making 
an early diagnosis of ISCM could lead to a prompt decision of 
the necessity of major intervention. Providing patients with 
successful palliation and improving their quality of life demand 
multidisciplinary strategic treatment planning2,11,13).